Zynex, Inc. (ZYXI )

Currency in USD Disclaimer
$2.91 -$0.51 (-14.81%)
Open 03/14/2025
$2.77
$3.5
$2.77
$13.19

Company brief: ZYNEX, INC. (ZYXI )


Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

ZYXI Corporation News

Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

March 13, 2025 at 7:00 pm ET

businesswire.com -- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zynex, Inc. (“Zynex” ...

Zynex, Inc. (ZYXI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 13, 2025 at 6:00 pm ET

businesswire.com -- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the Company's ...

Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 12, 2025 at 11:00 pm ET

businesswire.com -- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) on behalf of investors concerning the Company...

INVESTOR ALERT: Investigation of Zynex, Inc. (ZYXI) Announced by Holzer & Holzer, LLC

March 12, 2025 at 5:29 pm ET

globenewswire.com -- ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) complied with federal securities laws. On March...

Zynex's Sell-Off Creates A Speculative Buying Opportunity

March 12, 2025 at 3:12 pm ET

seekingalpha.com -- Zynex, Inc. specializes in non-invasive pain management and patient monitoring, with promising advancements like the NiCO pulse oximeter targeting accurate readings for diverse skin tones. Despite dis...

Zynex, Inc. (ZYXI) Q4 2024 Earnings Call Transcript

March 12, 2025 at 2:09 am ET

seekingalpha.com -- Zynex, Inc. (NASDAQ:ZYXI ) Q4 2024 Earnings Conference Call March 11, 2025 4:15 PM ET Company Participants Brian Prenoveau - Investor Relations Thomas Sandgaard - Chairman of the Board, President, and...

Zynex delivers solid growth with rising orders and expanding product innovation

March 11, 2025 at 8:56 pm ET

proactiveinvestors.com -- Zynex Inc (NASDAQ:ZYXI) has reported its financial results for the fourth quarter and the full year 2024, with full-year revenue growing 4% to reach $192.4 million. The medical technology company spec...

Zynex Reports Fourth Quarter and Full Year 2024 Financial Results

March 11, 2025 at 8:08 pm ET

prnewswire.com -- ENGLEWOOD, Colo. , March 11, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain...

Income Statement